Roche to invest $50 billion in the U.S. as pharma tariff threat lingers

Roche to invest $50 billion in the US as tariff threats loom

Roche joins other European drugmakers that have announced US investments in recent months....

The pharmaceutical giant puts 50 billion dollars in its American locations. He wants to export more drugs from there instead of importing them – in the spirit of the president.

Pharma Giant Investing Billions In US

Roche, a swiss pharmaceutical giant will invest billions of dollars into the United States over the next five years. Breitbart reported: Swiss pharmaceutical giant Roche announced Tuesday it will invest upwards of $50 billion in the United States over the next five years, a move that follows in the wake of President Donald Trump’s announcement of proposed tariffs on imported drugs. The U.S. is a critical market for the pharmaceutical industry, r…

Swiss pharmaceuticals company Roche picks Indiana for new plant, announces $50B investment in US over next 5 years

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.

Two major international pharmaceutical companies have announced million-dollar investments in the country. Last week we learned about the creation of new factories, more than 9,000 new jobs and the possibility of delivering health-focused products more efficiently in North America.Read more]]>

The Swiss group made the decision to invest to further strengthen its current production capacity in the USA after threats from customs duties, since more than half of its sales are in the country.